Daphne Lobeek studied Technical Medicine at the University of Twente, Enschede, The Netherlands, and graduated in May 2016 cum laude. Driven by her enthusiasm and interest in advanced medical imaging technologies for diagnosis and therapy, she started her doctoral study on dimeric radiolabeled RGD peptides for PET/CT imaging of angiogenesis at the same department under supervision of prof. dr. Wim Oyen, prof. dr. Otto Boerman, dr. Mark Rijpkema, and dr. Erik Aarntzen. Her research focused on the translation of results from preclinical studies in a clinic setting, where she investigated the feasibility of RGD PET/CT in patients with head and neck cancer and arteriovenous malformations. From July 2018, she works for the clinical physicists’ team of the Department of Radiology and Nuclear Medicine (Radboud University Medical Center, Nijmegen). Her tasks involves the support of researchers from the own department and other disciplines to develop and execute the analyses of advanced technologies involving radiation, and to take care of the policy in the field of radiation safety issues.